Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Please find enclosed the Scrutinizer's Report on the e-voting conducted from 5th May 2018 to 7th May 2018 and polling conducted at the venue of the Annual General Meeting.09-05-2018
09-05-2018
Summary Of Proceedings Of 62Nd Annual General Meeting Held On 8Th May 2018
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a summary of proceedings of the 62nd Annual General Meeting of the Company held on 8th May 2018 at Hall of Culture, Nehru Centre, Dr. Annie Besant Road, Worli, Mumbai.09-05-2018
Sanofi India March quarter profit rises 37% at Rs82 crore
Sanofi India reported 37.27% rise in net profit to Rs82.5 crore for the quarter ended 31 March 2018 as against Rs60.1 crore in the same period last fiscal08-05-2018
Change In Chief Financial Officer With Effect From 1St July 2018
As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at its meeting held on 8th May 2018 approved appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel with effect from 1st July 2018....08-05-2018
Results - Financial Results For Mar 31, 2018
We refer to our letter dated 23rd April 2018 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 11.00 a.m. and concluded at 1.00 p.m. The Board approved unaudited financial results for the quarter ended 31st March 2018. We enclose a copy of the unaudited financial results of the Company for the quarter ended...08-05-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.24-04-2018
Board Meeting - Board Meeting On May 08,2018
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 8th May 2018; inter alia to consider the unaudited financial results for the quarter ended 31st March 2018, which is the first quarter of the Company's financial year (Q1).23-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0211 Name of the Signatory :- Girish TekchandaniDesignation :- Company Secretary and Compliance Officer19-04-2018
Advent is said to near deal to acquire Sanofi Generics unit
The sale would add to the more than $15 billion in transactions that Sanofi has announced so far this year, including the acquisition of Bioverativ Inc. and Ablynx NV16-04-2018
Shareholding for the Period Ended March 31, 2018
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here13-04-2018